Slide
Newsroom
Latest News
Exciting things are happening at Aulos Bioscience. Here is the latest news about our company and pipeline.
Recent Posts
- Aulos Bioscience Presents Preclinical Data Demonstrating Anti-Tumor Activity of AU-007, a Novel IL-2 Therapeutic, at 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting November 12, 2021
- Aulos Bioscience to Present New Preclinical Data on Computationally Evolved IL-2 Human Antibody AU-007 at 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting October 5, 2021
- Jim Vasselli, M.D., Joins Aulos Bioscience as Chief Medical Officer June 14, 2021
- Aulos Bioscience Appoints Leo Redmond as Chief Financial Officer May 17, 2021
- Mace Rothenberg, M.D., Joins Aulos Bioscience Board of Directors March 30, 2021
- Aulos Bioscience Appoints Aron Knickerbocker as CEO March 15, 2021
- ATP and Biolojic Design Launch Aulos Bioscience to Develop Highly Differentiated IL-2 Antibody Approach to Fighting Cancer January 8, 2021